Around 125 students from Tutong Sixth Form Centre (PTET) took part in the Brunei Darussalam AIDS Council’s (BDAIDSCouncil) ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases offering hope to patients with limited alternatives A significant breakthrough in treating the Human Immunodeficiency Virus HI ...

This manuscript provides valuable information about the genesis of CPSF6 condensates due to HIV-1 infection. However, the evidence is incomplete as it is missing more functional assays. Furthermore, ...

Zambia led the way as the first sub-Saharan African country to introduce CAB-LA, a new WHO-recommended HIV prevention drug, ...

Reports indicate that Cambodia plans to introduce Pre-Exposure Prophylaxis (PrEP) for HIV prevention by early 2025. However, ...

Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US ...

While there have been positive shifts in some areas—such as the introduction of community-led models for HIV prevention—these efforts remain largely isolated and lack the robust support needed ...

We are pleased to have received the earlier than expected regulatory approval from the WHO to begin the later-stage manufacturing processes of both of our rapid HIV tests, TrinScreen HIV and Uni-Gold ...

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.

The Department of Health and Human Services allocated at least $73.9 million in grant funding to programs aimed at either mitigating the alleged harm racism causes minorities living with HIV or ...